Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer and Metastasis Reviews
Published in: Cancer and Metastasis Reviews 4/2018

01-12-2018

Preface

Author: Stephanie Tucker

Published in: Cancer and Metastasis Reviews | Issue 4/2018

Login to get access

Excerpt

In the last decade, researchers have made a concerted effort to move beyond their restrictive silos so as to practice cross-discipline studies in ways that have led to some paradigm-shifting observations and practices. This is an exciting era of discovery as so-called system approaches become multi-system studies. The new discoveries and methods highlighted in this issue will likely expedite solutions for some of the more enigmatic diseases, such as ophthalmic and male breast cancer, for example. …
Metadata
Title
Preface
Author
Stephanie Tucker
Publication date
01-12-2018
Publisher
Springer US
Published in
Cancer and Metastasis Reviews / Issue 4/2018
Print ISSN: 0167-7659
Electronic ISSN: 1573-7233
DOI
https://doi.org/10.1007/s10555-018-09776-z

Other articles of this Issue 4/2018

Cancer and Metastasis Reviews 4/2018 Go to the issue

NON-THEMATIC REVIEW

Cross-talk between lung cancer and bones results in neutrophils that promote tumor progression

OriginalPaper

Mitochondrial polymorphisms contribute to aging phenotypes in MNX mouse models

Announcement

Biography—Stephanie Tucker

ReviewPaper

From genomics to metabolomics: emerging metastatic biomarkers in osteosarcoma

OriginalPaper

Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment

OriginalPaper

Metabolic reprogramming of mitochondrial respiration in metastatic cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits